Functional anatomy of distant-acting mammalian enhancers

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1620, 2013, Pages

  Dickel, D E ^a   Visel, A ^a,b   Pennacchio, L A ^a,b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b DOE JOINT GENOME INSTITUTE   (United States)

Author keywords

Enhancer; Gene regulation; Mouse genomics; Mutation

Indexed keywords

ANATOMY; ETIOLOGY; GENOME; MUTATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RODENT;

SALL1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ALLELE; ANIMAL; ANTIBODY SPECIFICITY; BINDING SITE; EMBRYOLOGY; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC DISORDER; GENETICS; HUMAN; LIMB; MAMMAL; METABOLISM; MUTATION; TRANSCRIPTION INITIATION;

ALLELES; ANIMALS; BINDING SITES; ENHANCER ELEMENTS, GENETIC; EXTREMITIES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC DISEASES, INBORN; HUMANS; MAMMALS; MUTATION; ORGAN SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84891375981     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0359     Document Type: Review

References (61)

1. Visel A, Rubin EM, Pennacchio LA. 2009 Genomic views of distant-acting enhancers. Nature 461, 199-205. (doi:10.1038/nature08451)
2. Ptashne M. 1986 Gene regulation by proteins acting nearby and at a distance. Nature 322, 697-701. (doi:10.1038/322697a0)
3. Li Q, Barkess G, Qian H. 2006 Chromatin looping and the probability of transcription. Trends Genet. 22, 197-202. (doi:10.1016/j.tig.2006.02.004)
4. ENCODE Project Consortium Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. 2012 An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74. (doi:10.1038/ nature11247)
5. May D et al. 2012 Large-scale discovery of enhancers from human heart tissue. Nat. Genet. 44, 89-93. (doi:10.1038/ng.1006)
6. Maurano MT et al. 2012 Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190-1195. (doi:10.1126/ science.1222794)
7. 1000 Genomes Project Consortium. 2010 A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073. (doi:10.1038/ nature09534)
8. Su J, Teichmann SA, Down TA. 2010 Assessing computational methods of cis-regulatory module prediction. PLoS Comput. Biol. 6, e1001020. (doi:10. 1371/journal.pcbi.1001020)
9. Zinzen RP, Girardot C, Gagneur J, Braun M, Furlong EEM. 2009 Combinatorial binding predicts spatiotemporal cis-regulatory activity. Nature 462, 65-70. (doi:10.1038/nature08531)
10. Kioussis D, Vanin E, deLange T, Flavell RA, Grosveld FG. 1983 b-globin gene inactivation by DNA translocation in gamma beta-thalassaemia. Nature 306, 662-666. (doi:10.1038/306662a0)
11. Semenza GL, Delgrosso K, Poncz M, Malladi P, Schwartz E, Surrey S. 1984 The silent carrier allele: beta thalassemia without a mutation in the betaglobin gene or its immediate flanking regions. Cell 39, 123-128. (doi:10.1016/0092-8674(84)90197-1)
12. Lettice LA et al. 2002 Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. Proc. Natl Acad. Sci. USA 99, 7548-7553. (doi:10.1073/pnas.112212199)
13. Balemans W et al. 2002 Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet. 39, 91-97. (doi:10.1136/jmg.39.2.91)
14. Staehling-Hampton K et al. 2002 A 52 kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am. J. Med. Genet. 110, 144-152. (doi:10.1002/ajmg.10401)
15. Collette NM, Genetos DC, Economides AN, Xie L, Shahnazari M, Yao W, Lane NE, Harland RM, Loots GG. 2012 Targeted deletion of Sost distal enhancer increases bone formation and bonemass. Proc. Natl Acad. Sci. USA 109, 14092-14097. (doi:10.1073/pnas.1207188109)
16. Emison ES et al. 2005 A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 434, 857-863. (doi:10.1038/nature03467)
17. Lauderdale JD, Wilensky JS, Oliver ER, Walton DS, Glaser T. 2000 30 deletions cause aniridia by preventing PAX6 gene expression. Proc. Natl Acad. Sci. USA 97, 13755-13759. (doi:10.1073/pnas. 240398797)
18. Kleinjan DA, Lettice LA. 2008 Long-range gene control and genetic disease. Adv. Genet. 61, 339-388. (doi:10.1016/S0065-2660(07)00013-2)
19. Ernst J et al. 2011 Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43-49. (doi:10.1038/nature09906)
20. McCarroll SA et al. 2008 Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet. 40, 1107-1112. (doi:10.1038/ng.215)
21. Prescott NJ et al. 2010 Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease. Hum. Mol. Genet. 19, 1828-1839. (doi:10.1093/hmg/ddq041)
22. Vacic V et al. 2011 Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 471, 499-503. (doi:10.1038/ nature09884)
23. Helgadottir A et al. 2007 A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491-1493. (doi:10.1126/ science.1142842)
24. McPherson R et al. 2007 A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488-1491. (doi:10.1126/ science.1142447)
25. Visel A et al. 2010 Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464, 409-412. (doi:10.1038/ nature08801)
26. Harismendy O et al. 2011 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 470, 264-268. (doi:10.1038/nature09753)
27. Gudmundsson J et al. 2007 Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet. 39, 977-983. (doi:10.1038/ng2062)
28. Zhang X, Cowper-Sal Lari R, Bailey SD, Moore JH, Lupien M. 2012 Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus. Genome Res. 22, 1437-1446. (doi:10.1101/gr.135665.111)
29. Visel A et al. 2009 ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858. (doi:10.1038/nature07730)
30. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010 A method and server for predicting damaging missense mutations. Nat Methods 7, 248-249. (doi:10.1038/nmeth0410-248)
31. Kumar P, Henikoff S, Ng PC. 2009 Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081. (doi:10.1038/nprot.2009.86)
32. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. 2011 Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745-755. (doi:10.1038/nrg3031)
33. Davidson EH. 1999 A view from the genome: spatial control of transcription in sea urchin development. Curr. Opin. Genet. Dev. 9, 530-541. (doi:10.1016/ S0959-437X(99)00013-1)
34. Borok MJ, Tran DA, Ho MCW, Drewell RA. 2010 Dissecting the regulatory switches of development: lessons from enhancer evolution in Drosophila. Development 137, 5-13. (doi:10.1242/dev.036160)
35. Arnosti DN, Kulkarni MM. 2005 Transcriptional enhancers: intelligent enhanceosomes or flexible billboards? J. Cell. Biochem. 94, 890-898. (doi:10. 1002/jcb.20352)
36. Thanos D, Maniatis T. 1995 Virus induction of human IFN b gene expression requires the assembly of an enhanceosome. Cell 83, 1091-1100. (doi:10.1016/0092-8674(95)90136-1)
37. Goodbourn S, Maniatis T. 1988 Overlapping positive and negative regulatory domains of the human beta-interferon gene. Proc. Natl Acad. Sci. USA 85, 1447-1451. (doi:10.1073/pnas.85.5.1447)
38. Du W, Maniatis T. 1992 An ATF/CREB binding site is required for virus induction of the human interferon beta gene. Proc. Natl Acad. Sci. USA 89, 2150-2154. (doi:10.1073/pnas.89.6.2150)
39. Panne D, Maniatis T, Harrison SC. 2007 An atomic model of the interferon-beta enhanceosome. Cell 129, 1111-1123. (doi:10.1016/j.cell.2007.05.019)
40. Panne D, Maniatis T, Harrison SC. 2004 Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J. 23, 4384-4393. (doi:10.1038/sj.emboj.7600453)
41. Swanson CI, Evans NC, Barolo S. 2010 Structural rules and complex regulatory circuitry constrain expression of a Notch- and EGFR-regulated eye enhancer. Dev. Cell 18, 359-370. (doi:10.1016/j. devcel.2009.12.026)
42. Liu F, Posakony JW. 2012 Role of architecture in the function and specificity of two notch-regulated transcriptional enhancer modules. PLoS Genet. 8, e1002796. (doi:10.1371/journal.pgen.1002796)
43. Nagy A, Gertsenstein M, Vintersten K, Behringer R. 2003 Manipulating the mouse embryo, 3rd edn. Cold Spring Harbor, NY: CSHL Press.
44. Rojas A, De Val S, Heidt AB, Xu S-M, Bristow J, Black BL. 2005 Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element. Development 132, 3405-3417. (doi:10.1242/dev.01913)
45. Rojas A, Schachterle W, Xu S-M, Black BL. 2009 An endoderm-specific transcriptional enhancer from the mouse Gata4 gene requires GATA and homeodomain protein-binding sites for function in vivo. Dev. Dyn. 238, 2588-2598. (doi:10.1002/dvdy.22091)
46. Munshi NV, McAnally J, Bezprozvannaya S, Berry JM, Richardson JA, Hill JA, Olson EN. 2009 Cx30.2 enhancer analysis identifies Gata4 as a novel regulator of atrioventricular delay. Development 136, 2665-2674. (doi:10.1242/dev.038562)
47. Lettice LA et al. 2012 Opposing functions of the ETS factor family define Shh spatial expression in limb buds and underlie polydactyly. Dev. Cell 22, 459-467. (doi:10.1016/j.devcel.2011.12.010)
48. Lettice LA, Hill AE, Devenney PS, Hill RE. 2008 Point mutations in a distant sonic hedgehog cis-regulator generate a variable regulatory output responsible for preaxial polydactyly. Hum. Mol. Genet. 17, 978-985. (doi:10.1093/hmg/ddm370)
49. Lettice LA et al. 2003 A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum. Mol. Genet. 12, 1725-1735. (doi:10.1093/hmg/ddg180)
50. Maas SA, Suzuki T, Fallon JF. 2011 Identification of spontaneous mutations within the long-range limbspecific Sonic hedgehog enhancer (ZRS) that alter Sonic hedgehog expression in the chicken limb mutants oligozeugodactyly and silkie breed. Dev. Dyn. 240, 1212-1222. (doi:10.1002/dvdy.22634)
51. Pennacchio LA et al. 2006 In vivo enhancer analysis of human conserved non-coding sequences. Nature 444, 499-502. (doi:10.1038/nature05295)
52. Nishinakamura R et al. 2001 Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development 128, 3105-3115.
53. Rosenthal N. 1987 Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol. 152, 704-720. (doi:10.1016/ 0076-6879(87)52075-4)
54. Naylor LH. 1999 Reporter gene technology: the future looks bright. Biochem. Pharmacol. 58, 749-757. (doi:10.1016/S0006-2952(99)00096-9)
55. Schenborn E, Groskreutz D. 1999 Reporter gene vectors and assays. Mol. Biotechnol. 13, 29-44. (doi:10.1385/MB:13:1:29)
56. Melnikov A et al. 2012 Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat. Biotechnol. 30, 271-277. (doi:10.1038/nbt.2137)
57. Patwardhan RP et al. 2012 Massively parallel functional dissection of mammalian enhancers in vivo. Nat. Biotechnol. 30, 265-270. (doi:10.1038/ nbt.2136)
58. Liu F, Song Y, Liu D. 1999 Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258-1266. (doi:10. 1038/sj.gt.3300947)
59. Schachterle W, Rojas A, Xu S-M, Black BL. 2012 ETSdependent regulation of a distal Gata4 cardiac enhancer. Dev. Biol. 361, 439-449. (doi:10.1016/j. ydbio.2011.10.023)
60. Rojas A, Schachterle W, Xu S-M, Martín F, Black BL. 2010 Direct transcriptional regulation of Gata4 during early endoderm specification is controlled by FoxA2 binding to an intronic enhancer. Dev. Biol. 346, 346-355. (doi:10.1016/j.ydbio.2010.07. 032)
61. Poulin F, Nobrega MA, Plajzer-Frick I, Holt A, Afzal V, Rubin EM, Pennacchio LA. 2005 In vivo characterization of a vertebrate ultraconserved enhancer. Genomics 85, 774-781. (doi:10.1016/j. ygeno.2005.03.003)